hameln pharmaceuticals ltd

Nexus, Gloucester Business Park, Gloucester, GL3 4AG
Telephone: +44 (0)1452 621 661
Fax: +44 (0)1452 632 732
WWW: http://www.hameln.co.uk
Medical Information e-mail: drugsafety@hameln.co.uk

Patient Information Leaflet last updated on the eMC: 20/11/2009
PIL Metoclopramide 5mg/ml Injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 20/11/2009 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
  • Change to drug interactions
Updated on 08/07/2009 and displayed until 20/11/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 30/05/2008 and displayed until 08/07/2009
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   metoclopramide hydrochloride